Corvus Pharmaceuticals
CRVS
#7822
Rank
NZ$0.41 B
Marketcap
$6.13
Share price
3.98%
Change (1 day)
141.11%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2023 (TTM): -$1.39

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.41. In 2022 the company made an earnings per share (EPS) of -$1.49 an increase over its 2021 EPS that were of -$1.78.

EPS history for Corvus Pharmaceuticals from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.39-6.81%
2022-$1.49-16.04%
2021-$1.78404.76%
2020-$0.35-86.79%
2019-$2.66-9.14%
2018-$2.93-35.66%
2017-$4.56-60.47%
2016-$11.53348.05%
2015-$2.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.65 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA